Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Politics for Pros- moderated -- Ignore unavailable to you. Want to Upgrade?

To: LindyBill who wrote (12961)	10/19/2003 6:37:36 AM
From: Lizzie Tudor	Read Replies (2) \| Respond to of 793670

This should help in the battle to stop the cheap distribution channels. Sounds like a slight underlying shill for the anticompetitive stance of the republicans and the current FDA (the safety excuse for the closed drug market, I mean)

To: LindyBill who wrote (12961)	10/19/2003 1:21:23 PM
From: skinowski	Respond to of 793670

Interesting. Thanks. Will follow the series. Often medications are obscenely expensive. Some 20 years ago I noted that most new medications coming into the market were, for some reason - almost as a rule - all priced around $25-35 a month. Nowadays, they upped it to $50 - 90 a month or more. (These are just anecdotal observations, of course, fwiw). Remember that many people take several medications. Anyway, it is not surprising that such large amounts af cash changing hands have attracted criminals. By paying more for medications than other countries the US, in effect, has been subsidizing pharmaceutical R&D for the rest of the world. It seems that the Big Pharma pressed Americans a little too hard, and we are getting tired of giving everyone else a free ride. jmho.